Detalhe da pesquisa
1.
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.
Mol Cell
; 80(6): 1104-1122.e9, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259812
2.
Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.
Mol Cell
; 81(1): 212, 2021 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417854
3.
Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, Src-related Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal Myristoylation Sites (SRMS).
Mol Cell Proteomics
; 17(5): 925-947, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496907
4.
Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates.
Proteome Sci
; 16: 16, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30140170
5.
Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
Cancer Metastasis Rev
; 35(2): 179-99, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067725
6.
Tracing the footprints of the breast cancer oncogene BRK - Past till present.
Biochim Biophys Acta
; 1856(1): 39-54, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25999240
7.
Seeking a better understanding of the non-receptor tyrosine kinase, SRMS.
Heliyon
; 9(6): e16421, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37251450
8.
Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.
Nat Commun
; 13(1): 4043, 2022 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35831314
9.
Development of a low-cost and portable smart fluorometer for detecting breast cancer cells.
Biomed Opt Express
; 10(2): 399-410, 2019 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30800488
10.
FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition.
Oncotarget
; 8(68): 113034-113065, 2017 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348886
11.
Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways.
Cancer Biol Med
; 14(2): 129-141, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607804
12.
BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
PLoS One
; 9(2): e87684, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24523872